Is AstraZeneca The Next Big Player In Cancer Immunotherapies?

A new drug could put British drug maker AstraZeneca "squarely in the IO fight" among drug makers developing therapies that use the body's immune system to kill cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.